RB1 expression
|
GBM
|
RB1 expression
|
GBM
|
palbociclib Resistant: C3 – Early Trials
|
palbociclib Resistant: C3 – Early Trials
|
RB1 expression
|
Liposarcoma
|
RB1 expression
|
Liposarcoma
|
palbociclib Sensitive: C3 – Early Trials
|
palbociclib Sensitive: C3 – Early Trials
|
RB1 expression
|
Soft Tissue Sarcoma
|
RB1 expression
|
Soft Tissue Sarcoma
|
palbociclib Sensitive: C3 – Early Trials
|
palbociclib Sensitive: C3 – Early Trials
|
RB1 expression
|
Prostate Cancer
|
RB1 expression
|
Prostate Cancer
|
palbociclib Sensitive: D – Preclinical
|
palbociclib Sensitive: D – Preclinical
|
RB1 expression
|
Breast Cancer
|
RB1 expression
|
Breast Cancer
|
CDK4 inhibitor + CDK6 inhibitor Sensitive: D – Preclinical
|
CDK4 inhibitor + CDK6 inhibitor Sensitive: D – Preclinical
|